Ignite Creation Date:
2024-07-17 @ 11:02 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06465550
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-06-12
Brief Title:
A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell BD211 Treating β-thalassemia Major
Sponsor:
Shanghai BDgene Co Ltd
Organization:
Shanghai BDgene Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| β-thalassemia |
Keywords: